Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-05-26
1999-11-09
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 9, 530317, C07K 764
Patent
active
059814799
ABSTRACT:
It has been found that nonimmunosuppressive, cyclophilin-binding cyclosporins are useful in the treatment and prevention of AIDS and AIDS-related disorders. Such cyclosporins include novel Ciclosporin derivatives modified at the 4- and/or 5-positions.
REFERENCES:
patent: 4148992 (1979-04-01), Sebek et al.
patent: 4639434 (1987-01-01), Wenger et al.
patent: 4771122 (1988-09-01), Seebach
patent: 4798823 (1989-01-01), Witzel
patent: 4814323 (1989-03-01), Andrieu et al.
patent: 4914188 (1990-04-01), Dumont et al.
patent: 5122511 (1992-06-01), Patchett et al.
Bartz et al, Proc Natl Acad of Sci, vol. 92, pp. 5381-5385, 1995.
Pauwels, et al, Journal of Virological Methods, 20, 309-321, 1988.
Karpas, et al, PNAS, vol. 89, pp. 8351-8355, 1992.
Billich et al, J. of Virology, vol. 69, No. 4, pp. 2451-2461, 1995.
Fahey et al., Clin. exp. Immunol., vol. 88, 1-5 (1992).
Stein et al, CID, vol. 17, 749-771 (1993).
Sigal, et al., J. Exp. Med., vol. 173, pp. 619-628, Mar. 1991.
Brini, et al., Cytokine Net., vol. 1, No. 3, pp. 131-139, Aug.-Sep. 1990.
Klatzmann, et al., C.R. Acad. Sc. Paris, t. 303, Serie III, No. 9, pp. 343-348, 1986.
Emmel et al., Science, vol. 246, pp. 1617-1620, Dec. 22, 1989.
Quesniaux, et al., Eur. J. Immunol., 17: 1359-1365, 1987.
Nabel et al., Nature, vol. 326, pp. 711-713, 1987.
Takahashi, et al., Nature, vol. 337, pp. 473-478, 1989.
Fischer, et al., Nature, vol. 337, pp. 476-478, 1989.
Schmidt, et al., Journal of Virology, vol. 64, No. 8, pp. 4037-4041, Aug. 1990.
Baumann, et al., The New Biologist, vol. 3, No. 3, pp. 270-278, Mar. 1991.
Lenardo, et al., Cell, vol. 58, pp. 227-229, Jul. 28, 1989.
Ruegger, et al., Helvetica Chimica Acta, vol. 59, Fasc. 4, No. 112, pp. 1075-1092, 1976.
Sebek, et al., The Journal of Antibiotics, vol. 37, No. 2, pp. 136-142, Feb. 1984.
Delort, et al., The Journal of Antibiotics, vol. 41, No. 7, pp. 916-924, 1988.
Vaufrey, et al., The Journal of Antibiotics, vol. 43, No. 9, pp. 1189-1191, 1990.
Traber, et al., Helvetica Chimica Acta, vol. 65, Fasc. 5, No. 162, pp. 1655-1677, 1982.
Sebekia et al., Abstrs. 82nd Ann. Meet Amer. Soc. Microbiol., 163, Atlanta, 1982.
Wenger, Sandorama, pp. 5-11, (1984/III).
Durette et al., Transplantation Proceedings, Vo. XX, No. 2, Suppl. 2, pp. 51-57 (1988).
Rosenwirth et al., Antimicrobial Agents and Chemotherapy, vol. 38, No. 8 pp. 1763-1772 (1994).
Steinkasserer et al., Journal of Virology, vol. 69, No. 2, pp. 814-824, (1995).
Thali et al., Letters to Nature, vol. 372, pp. 363-365 (1994).
Besemer-Rosenwirth Brigitte
Bollinger Pietro
Ko Soo Young
Kobel Hans
Seebach Dieter
Furman Diane E.
Lopez Gabriel
Novartis AG
Tsang Cecilia J.
LandOfFree
Cyclosporins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclosporins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclosporins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1455959